You are here
Home > News > Global Pediatric Vaccines Market Analysis, Share, Trends and Forecast by 2022

Global Pediatric Vaccines Market Analysis, Share, Trends and Forecast by 2022

According to Stratistics MRC, the Global Pediatric Vaccines market is estimated at $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Rising government and non-government financial support for development of vaccine is the major driver for the pediatric vaccine market. Increasing innovative technologies such as therapeutic and adjuvant vaccines are anticipated to fuel the pediatric vaccine market during the forecast period. Moreover, increasing expenditure of vaccines, little accessibility to remote areas and strict regulation for approval of vaccines are some of the factors hampering the global pediatric vaccine market.

Browse the report: http://www.orbisresearch.com/reports/index/pediatric-vaccines-global-market-outlook-2015-2022

Infectious diseases segment is expected to grow at a faster rate during the forecast period. North America dominates the global market for pediatric vaccines followed by Europe. Moreover, the Asia Pacific is likely to report the highest CAGR during the forecast period, driven by the high birth rate in China and India.

Some of the key players in the market include Johnson and Johnson, Abbott Laboratories, Baxter International, Eli Lilly and Company, Sanofi S.A, Novo Nordisk A/S, Bharat Biotech International Limited, Actelion Pharmaceuticals Ltd, Genentech, Inc., Shire Pharmaceuticals Group Plc, Merck & Co. Inc, Bristol-Myers Squibb Company, Amgen Inc., Novartis AG and Boehringer Ingelheim GmbH.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184631

Diseases type Covered:
Cancer and allergy
Infectious disease
Pneumococcal disease
Influenza
Diphtheria
Rotavirus
Tetanus
Haemophilus Influenzae type b (Hib)
Meningococcal
Hepatitis A
Hepatitis B
Rubella
Mumps
Measles
Pertussis
Varicella (chickenpox)
Polio

Products Covered:
Anti-infective drugs
Pediatric hormones
Allergy & respiratory drugs
CNS drugs

Vaccines type Covered:
Synthetic vaccines
Conjugate vaccines
Live attenuated vaccines
Dendritic cells vaccines
Toxoid vaccines
Recombinant vector vaccines
Subunit vaccines
Inactivated vaccines

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Leave a Reply

Top